1
|
Maulucci F, Disanto G, Bianco G, Pileggi M, Fischer U, Padlina G, Strambo D, Michel P, Kahles T, Nedeltchev K, Fisch U, Bonati L, Kägi G, Escribano Paredes JB, Carrera E, Nyffeler T, Bolognese M, Wegener S, Luft A, Schelosky L, Medlin F, von Reding A, Peters N, Renaud S, Mono ML, Remonda L, Machi P, Psychogios MN, Kaesmacher J, Mordasini P, Cereda CW. Endovascular therapy outcome in isolated posterior cerebral artery occlusion strokes: A multicenter analysis of the Swiss Stroke Registry. Eur Stroke J 2023; 8:575-580. [PMID: 37231695 PMCID: PMC10334166 DOI: 10.1177/23969873221150125] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2023] Open
Abstract
PURPOSE There is little data on the safety and efficacy of endovascular treatment (EVT) in comparison with intravenous thrombolysis (IVT) in acute ischemic stroke due to isolated posterior cerebral artery occlusion (IPCAO). We aimed to investigate the functional and safety outcomes of stroke patients with acute IPCAO treated with EVT (with or without prior bridging IVT) compared to IVT alone. METHODS We did a multicenter retrospective analysis of data from the Swiss Stroke Registry. The primary endpoint was overall functional outcome at 3 months in patients undergoing EVT alone or as part of bridging, compared with IVT alone (shift analysis). Safety endpoints were mortality and symptomatic intracranial hemorrhage. EVT and IVT patients were matched 1:1 using propensity scores. Differences in outcomes were examined using ordinal and logistic regression models. FINDINGS Out of 17,968 patients, 268 met the inclusion criteria and 136 were matched by propensity scores. The overall functional outcome at 3 months was comparable between the two groups (EVT vs IVT as reference category: OR = 1.42 for higher mRS, 95% CI = 0.78-2.57, p = 0.254). The proportion of patients independent at 3 months was 63.2% in EVT and 72.1% in IVT (OR = 0.67, 95% CI = 0.32-1.37, p = 0.272). Symptomatic intracranial hemorrhages were overall rare and present only in the IVT group (IVT = 5.9% vs EVT = 0%). Mortality at 3 months was also similar between the two groups (IVT = 0% vs EVT = 1.5%). CONCLUSION In this multicenter nested analysis, EVT and IVT in patients with acute ischemic stroke due to IPCAO were associated with similar overall good functional outcome and safety. Randomized studies are warranted.
Collapse
Affiliation(s)
- F Maulucci
- Stroke Centre, Neurology Department, Neurocentre of Southern Switzerland, EOC, Lugano, Switzerland
| | - G Disanto
- Stroke Centre, Neurology Department, Neurocentre of Southern Switzerland, EOC, Lugano, Switzerland
| | - G Bianco
- Stroke Centre, Neurology Department, Neurocentre of Southern Switzerland, EOC, Lugano, Switzerland
| | - M Pileggi
- Stroke Centre, Interventional and Diagnostic Neuroradiology, Neurocentre of Southern Switzerland, EOC, Lugano, Switzerland
| | - U Fischer
- Department of Neurology, University Hospital Bern, Bern, Switzerland
- Department of Neurology and Stroke Centre, University Hospital Basel, Basel, Switzerland
| | - G Padlina
- Department of Neurology, University Hospital Bern, Bern, Switzerland
| | - D Strambo
- Lausanne University Hospital, Stroke Centre, Neurology Service, Lausanne, Switzerland
| | - P Michel
- Lausanne University Hospital, Stroke Centre, Neurology Service, Lausanne, Switzerland
| | - T Kahles
- Department of Neurology, Kantonsspital Aarau, Aarau, Switzerland
| | - K Nedeltchev
- Department of Neurology, Kantonsspital Aarau, Aarau, Switzerland
| | - U Fisch
- Department of Neurology and Stroke Centre, University Hospital Basel, Basel, Switzerland
| | - L Bonati
- Department of Neurology and Stroke Centre, University Hospital Basel, Basel, Switzerland
| | - G Kägi
- Department of Neurology, Kantonsspital St. Gallen, St. Gallen, Switzerland
| | | | - E Carrera
- Department of Neurology, Hôpitaux Universitaires de Genève, Geneva, Switzerland
| | - T Nyffeler
- Luzerner Kantonsspital, Centre of Neurology and Neurorehabilitation, Luzern, Switzerland
| | - M Bolognese
- Luzerner Kantonsspital, Centre of Neurology and Neurorehabilitation, Luzern, Switzerland
| | - S Wegener
- Universitätsspital Zürich, Neurology, Zürich, Switzerland
| | - A Luft
- Universitätsspital Zürich, Neurology, Zürich, Switzerland
| | - L Schelosky
- Kantonsspital Münsterlingen, Division of Neurology, Münsterlingen, Switzerland
| | - F Medlin
- Stroke Unit, Division of Neurology, HFR Fribourg, Fribourg, Switzerland
| | - A von Reding
- Neurology, Kantonsspital Winterthur, Winterthur, Switzerland
| | - N Peters
- Stroke Centre, Klinik Hirslanden, Zurich, Switzerland
| | - S Renaud
- Division of Neurology, Pourtalès Hospital, Neuchatel, Switzerland
| | - M-L Mono
- Stadtspital Waid und Triemli, Stroke Unit, Zürich, Switzerland
| | - L Remonda
- Department of Interventional Neuroradiology, Kantonsspital Aarau, Aarau, Switzerland
| | - P Machi
- Department of Interventional Neuroradiology, Hôpitaux Universitaires de Genève, Geneva, Switzerland
| | - M-N Psychogios
- Department of Interventional Neuroradiology, University Hospital Basel, Basel, Switzerland
| | - J Kaesmacher
- University Hospital Bern, Inselspital, Interventional Neuroradiology, Bern, Switzerland
| | - P Mordasini
- University Hospital Bern, Inselspital, Interventional Neuroradiology, Bern, Switzerland
| | - C W Cereda
- Stroke Centre, Neurology Department, Neurocentre of Southern Switzerland, EOC, Lugano, Switzerland
- Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland
| |
Collapse
|
2
|
Renaud S, Dussutour A, Daboussi F, Pompon D. Characterization of chitinases from the GH18 gene family in the myxomycete Physarum polycephalum. Biochim Biophys Acta Gen Subj 2023; 1867:130343. [PMID: 36933625 DOI: 10.1016/j.bbagen.2023.130343] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2022] [Revised: 02/19/2023] [Accepted: 03/02/2023] [Indexed: 03/18/2023]
Abstract
BACKGROUND Physarum polycephalum is an unusual macroscopic myxomycete expressing a large range of glycosyl hydrolases. Among them, enzymes from the GH18 family can hydrolyze chitin, an important structural component of the cell walls in fungi and in the exoskeleton of insects and crustaceans. METHODS Low stringency sequence signature search in transcriptomes was used to identify GH18 sequences related to chitinases. Identified sequences were expressed in E. coli and corresponding structures modelled. Synthetic substrates and in some cases colloidal chitin were used to characterize activities. RESULTS Catalytically functional hits were sorted and their predicted structures compared. All share the TIM barrel structure of the GH18 chitinase catalytic domain, optionally fused to binding motifs, such as CBM50, CBM18, and CBM14, involved in sugar recognition. Assessment of the enzymatic activities following deletion of the C-terminal CBM14 domain of the most active clone evidenced a significant contribution of this extension to the chitinase activity. A classification based on module organization, functional and structural criteria of characterized enzymes was proposed. CONCLUSIONS Physarum polycephalum sequences encompassing a chitinase like GH18 signature share a modular structure involving a structurally conserved catalytic TIM barrels decorated or not by a chitin insertion domain and optionally surrounded by additional sugar binding domains. One of them plays a clear role in enhancing activities toward natural chitin. GENERAL SIGNIFICANCE Myxomycete enzymes are currently poorly characterized and constitute a potential source for new catalysts. Among them glycosyl hydrolases have a strong potential for valorization of industrial waste as well as in therapeutic field.
Collapse
Affiliation(s)
| | - Audrey Dussutour
- Centre de Recherche en Cognition Animale, UMR 5169 CNRS, Université Toulouse III, Toulouse, France
| | | | - Denis Pompon
- Toulouse Biotechnology Institute, UMR CNRS / INRAE / INSA, Université de Toulouse, Toulouse, France.
| |
Collapse
|
3
|
Moranne O, Gerbal M, Cariou S, Pambrun E, Garo F, Renaud S, Prouvot J, Reboul P, Messikh Z. Étude randomisée monocentrique comparant HD intermittente avec anticoagulation régionale au citrate vs prédilution avec rinçage initiale héparine sur le succès d’une séance de 4 h chez des patients à risque hémorragique. Nephrol Ther 2022. [DOI: 10.1016/j.nephro.2022.07.095] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
4
|
Garo F, Aglaé C, Cariou S, Reboul P, Gerbal M, Renaud S, Pambrun E, Messikh Z, Moranne O. Performance technique, diagnostic et complications de la biopsie rénale dans la cohorte monocentrique CKD-Caremeau. Nephrol Ther 2022. [DOI: 10.1016/j.nephro.2022.07.325] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
5
|
Benbouchaib S, Ruuth Praz J, Nadjafizadeh L, Treffel G, Seitlinger J, Renaud S, Knoepfli A, Chabot F, Brindel A. Évaluation de l’impact de la mise en place d’une consultation d’urgence oncologique thoracique sur les délais de prise en charge au cours de la pandémie de COVID-19. Revue des Maladies Respiratoires Actualités 2022. [PMCID: PMC8709634 DOI: 10.1016/j.rmra.2021.11.351] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
Introduction L’allongement du délai de prise en charge initial des cancers broncho-pulmonaires (CBP) aboutit à une progression de la maladie. Une consultation d’urgence oncologique dédiée à la prise en charge de patients ayant une suspicion de CBP a été mise en place au CHRU de Nancy le 1er novembre 2019. La pandémie de COVID-19 a entrainé une sanctuarisation du système de soins, complexifiant la prise en charge des CBP. Peu de données sont disponibles concernant le rôle de programme d’accès rapide au cours de cette pandémie. L’objectif principal est d’évaluer les délais de prise en charge (diagnostique et thérapeutique) après la mise en place d’une consultation d’urgence oncologique thoracique (UOT) et de l’impact de la pandémie de COVID-19 sur ces délais. Méthodes Étude rétrospective au CHRU de Nancy. La population est constituée des patients adressés en UOT entre novembre 2019 et février 2021. Les délais analysés sont le délai diagnostique et le délai thérapeutique. Les patients d’UOT sont classés en 2 groupes. Population « UOT pré-COVID-19 » dont le diagnostic est obtenu avant le 1er mars 2020, population UOT « COVID-19 » dont le diagnostic est obtenu après le 1er mars. Les délais des populations UOT sont comparés aux délais de la population témoin avant UOT, pris en charge au CHRU de Nancy de novembre 2014 à octobre 2015. Résultats Cent six patients ayant bénéficié d’une UOT ont été inclus: 15 patients dans UOT pré-COVID-19 et 91 patients dans UOT COVID-19. Deux cent dix sept patients constituaient la population témoin. Le délai diagnostique moyen était significativement plus court dans le groupe UOT pré-COVID-19, 48,8 jours contre 89,2 jours dans la population témoin, p < 0,01. Les délais moyens diagnostique et thérapeutique n’étaient pas allongés dans le groupe UOT COVID-19 en comparaison à la population témoin, 85,7 contre 89,2 jours et 92 contre 95,3 jours respectivement. Chez les patients ayant bénéficié d’une UOT après le 1er mars 2020, on observait une tendance à la diminution du nombre de patients adressés à un stade localisé (stade I : 20 % contre 33 % dans la population témoin p = 0,07) et une diminution de la prise en charge chirurgicale. Il existait une diminution du nombre de consultation pendant les deux confinements. Conclusion La consultation UOT a significativement diminué le délai diagnostique avant la pandémie de COVID-19. Lors de la pandémie, le nombre de consultations a diminué et les délais ont augmenté avec des patients se présentant à un stade plus avancé de la maladie.
Collapse
|
6
|
Clément-Duchêne C, Gilson P, Lacomme S, Yguel C, Renaud S, Billon Y. P68.15 Lung Cancer in Young Patients Under 45 Years: A French Study. J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.08.702] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
7
|
Atallah V, Poissonnet G, Roxanne E, Chand M, Anne S, Pauline G, Renaud S, Dorian C, Alexandre B, Sicurani J, Natale R, Hannoun-Levi J, Benezery K. PO-0851: Impact of Adjuvant Radiation Therapy for Advanced Cutaneous Squamous Cell Carcinoma of Head and Neck. Radiother Oncol 2020. [DOI: 10.1016/s0167-8140(21)00868-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
8
|
Campbell HM, Armstrong JF, Aoyama K, Biselli S, Cea J, de Rijk T, Dmytrow H, Dömsödi J, Friis-Wandall S, Gonzalez; P, Inerowicz D, Kirby P, Kozak A, Marley E, Marth-Schill J, Nordkvist E, Renaud S, Riter K, Roos A. Determination of Zearalenone in Cereal Grains, Animal Feed, and Feed Ingredients Using Immunoaffinity Column Chromatography and Liquid Chromatography: Interlaboratory Study. J AOAC Int 2019. [DOI: 10.1093/jaoac/90.6.1610] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
Abstract
Abstract
A method using immunoaffinity column chromatography (IAC) and liquid chromatography (LC) for determination of zearalenone in cereal grains, animal feed, and feed ingredients was collaboratively studied. The test portion is extracted by shaking with acetonitrilewater (90 + 10, v/v) and sodium chloride. The extract is diluted and applied to an immunoaffinity column, the column is washed with water or phosphatebuffered saline or methanolwater (30 + 70, v/v), and zearalenone is eluted with methanol. The eluate is evaporated, the residue is dissolved in mobile phase and analyzed by reversed-phase LC with fluorescence detection. The presence of zearalenone can be confirmed using an alternate excitation wavelength or diode array detection. Twenty samples were sent to 13 collaborators (8 in Europe, 2 in the United States, one in Japan, one in Uruguay, and one in Canada). Eighteen samples of naturally contaminated corn, barley, wheat, dried distillers grains, swine feed, and dairy feed were analyzed as blind duplicates, along with blank corn and wheat samples. The analyses were done in 2 sample sets with inclusion of a spiked wheat control sample (0.1 mg/kg) in each set. Spiked samples recoveries were 89116, and for the 18 naturally contaminated samples, RSDr values (within-laboratory repeatability) ranged from 6.67 to 12.1, RSDR values (among-laboratory reproducibility) ranged from 12.5 to 19.7, and HorRat values ranged from 0.61 to 0.90.
Collapse
Affiliation(s)
- Harold M Campbell
- Canadian Food Inspection Agency, Ottawa Laboratory (Carling), Ottawa, ON, Canada K1A 0C6
| | - J Fred Armstrong
- Canadian Food Inspection Agency, Ottawa Laboratory (Carling), Ottawa, ON, Canada K1A 0C6
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
9
|
Hannoun-Levi J, Daniele K, Benjamin G, Jocelyn G, Renaud S, Csaba P, Cristina G, Pieter N, Ravzan G, Kristina L, Bulent P, Georgy K, Erick V, Vratislav S. OC-0317 2nd Conservative Treatment for 2nd Breast Tumor Event: GEC-ESTRO Breast Cancer WG updated results. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)30737-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
10
|
Michaux JR, Hürner H, Krystufek B, Sarà M, Ribas A, Ruch T, Vekhnik V, Renaud S. Genetic structure of a European forest species, the edible dormouse ( Glis glis): a consequence of past anthropogenic forest fragmentation? Biol J Linn Soc Lond 2019. [DOI: 10.1093/biolinnean/bly176] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Affiliation(s)
- J R Michaux
- Conservation Genetics Laboratory, Institut de Botanique, Chemin de la Vallée, Liège, Belgium
- CIRAD/INRA UMR117 ASTRE, Campus International de Baillarguet, Montpellier Cedex 5, France
| | - H Hürner
- Conservation Genetics Laboratory, Institut de Botanique, Chemin de la Vallée, Liège, Belgium
| | - B Krystufek
- Slovenian Museum of Natural History, Presernova, Ljubljana, Slovenia
| | - M Sarà
- Dipartimento STEBICEF, Via Archirafi, Palermo, Italy
| | - A Ribas
- Museu de Granollers-Ciències Naturals C/Francesc Macià, Granollers, Spain
| | - T Ruch
- Institute for Cell Biology and Neuroscience, Johann Wolfgang-Goethe Universität Frankfurt am Main, Frankfurt am Main, Germany
| | - V Vekhnik
- Zhiguli State Nature Reserve, Bakhilova Polyana Village, Samara Oblast, Russia
| | - S Renaud
- Laboratoire de Biométrie et Biologie Evolutive, UMR 5558, Université Lyon, CNRS, Villeurbanne, France
| |
Collapse
|
11
|
Lefèvre E, Rolland LG, Vincent A, Renaud S, Alexandre K, Antoine D, Eric R, Ludovic D, Noëlle PM, Alfred M. Résultats au long cours de la transplantation rénale pour une vascularite associée aux ANCA : une analyse de 39 patients. Nephrol Ther 2018. [DOI: 10.1016/j.nephro.2018.07.394] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
12
|
Affiliation(s)
- A Beswick
- The Medical Research Council Epidemiology Unit Llandough Hospital Penarth, South Glam, UK
| | - S Renaud
- The INSERM, Unité 63, Bron, France
| | - J W G Yarnell
- The Medical Research Council Epidemiology Unit Llandough Hospital Penarth, South Glam, UK
| | - P C Elwood
- The Medical Research Council Epidemiology Unit Llandough Hospital Penarth, South Glam, UK
| |
Collapse
|
13
|
Renaud S, Latouk JG. Prevention by a Glucocorticoid of the Thrombotic and Hemorrhagic Tendencies Consecutive to Shock and Surgical Intervention in Rat. Thromb Haemost 2018. [DOI: 10.1055/s-0038-1653520] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Abstract
SummaryRats pretreated with acenocoumarin present a high incidence of hemorrhages from one to three days after an endotoxemic shock or a surgical intervention. The onset of hemorrhages is concomitant with a marked decrease in the platelet count and a considerable increase in the prothrombin time and the plasma clotting time. These hemorrhages as well as the changes in the parameters examined could be completely prevented by administration of triamcinolone at high doses (4 mg/kg), 2 hrs before and 2 hrs after the shock or the intervention.Three days after the induction of a traumatic shock in hyperlipemic rats the count and adhesiveness of blood platelets was markedly increased. At this time, the intravenous injection of an endotoxin (S. typhosa lipopolysaccharide) induced a much higher incidence of large phlebothromboses in these traumatized rats than in the control animals. Here again, administration of high doses of triamcinolone could completely block the consequences of the traumatic shock, namely the changes in the platelet count and adhesiveness and the increased thrombotic tendency.
Collapse
|
14
|
Abstract
SummaryTo determine whether the long-term feeding of dietary fats affect platelet functions in man, platelet aggregation (to thrombin ADP, collagen, epinephrine) and clotting activity of platelet-rich plasma (PRP), platelet-poor plasma and of washed platelets, were studied in a mobile-laboratory in 44 healthy male farmers (40-45 years) from two French regions Var and Moselle, in relation to lipemia, glycemia, dietary nutriments, and platelet phospholipid composition. In the Moselle subjects, the platelet clotting activity of PRP and of washed platelets, the platelet aggregation to thrombin and ADP, were highly significantly (p <0.001) increased as compared to those of Var, but not the plasma cholesterol, which was identical in the two regions.In Moselle, the intake of total calories, total lipids and saturated fats was higher than in the Var.However, it was only with the saturated fat intake (mostly stearic acid) that the platelet clotting activity (p <0.01) and the platelet aggregation (p <0.001) were highly significantly correlated. The platelet clotting activity was also significantly (p <0.001) correlated with the fatty acid composition of the platelet phospholipid fractions phosphatidyl serine + phosphatidyl inositol.
Collapse
Affiliation(s)
- S Renaud
- The INSERM, Unité 63, Lyon-Bron, France and the Department of Nutrition, University of Montreal, Montreal, Canada
| | - E Dumont
- The INSERM, Unité 63, Lyon-Bron, France and the Department of Nutrition, University of Montreal, Montreal, Canada
| | - F Godsey
- The INSERM, Unité 63, Lyon-Bron, France and the Department of Nutrition, University of Montreal, Montreal, Canada
| | - A Suplisson
- The INSERM, Unité 63, Lyon-Bron, France and the Department of Nutrition, University of Montreal, Montreal, Canada
| | - C Thevenon
- The INSERM, Unité 63, Lyon-Bron, France and the Department of Nutrition, University of Montreal, Montreal, Canada
| |
Collapse
|
15
|
Abstract
SummaryPlatelets collected with an EDTA solution and simply washed in an incomplete Tyrode’s presented clotting times in the recalcification (man and rat) and the Stypven (rat) tests that were practically identical to those of the PRP when slow speed centrifugation was used (800 G in man, 1000 G in rat). This was demonstrated, in 6 pools of 5 rats each and in 6 men, by comparing the clotting activity of the citrated platelet-rich plasma to that of the platelets washed and resuspended in the citrated platelet-poor plasma, for platelet counts ranging from 1 × 105 to 10 × 105/mm3. In contrast, centrifugation of platelets at 3000 G markedly affected these clotting activities, as was shown in an additional study comprising 6 pools of 3 rats.Finally, the clotting activity of platelets totally disrupted by sonication appears to be identical quantitatively in both man and rats to that of the total phospholipids extracted from these platelets and separated from the other lipids by thin-layer chromatography and resuspended in plasma by sonication.
Collapse
|
16
|
Abstract
SummaryAs evaluated in a recording “coagulometer” the Stypven time of 16 to 19 days pregnant Holtzman rats was shorter than that of the controls solely in platelet-rich plasma but not in platelet-poor plasma collected in siliconized material when most of the platelets were removed by slow speed centrifugation (1000 G × 20 minutes). If the same blood was centrifuged at a higher speed (2000 G) the Stypven time was considerably shorter in the pregnant rats even if no platelets were left indicating that platelet factor 3 had been released in plasma during centrifugation.Identical results were obtained in 10 women taking oral contraceptives as compared to 10 controls. Depending on whether blood was collected in siliconized glassware or not, and final determination performed in plastic or glass, the cephalin clotting time of oral contraceptives treated women was found to be longer, equal or shorter than this of the controls. When it was shorter, a comparable reduction in the Stypven time indicated that the shortening was probably due to “release” of platelet factor 3 in the platelet-poor plasma, in the course of its preparation.
Collapse
|
17
|
Abstract
SummaryHoltzman rats, 16 to 19 days pregnant, exhibited in vitro hypercoagulability with a 27 % reduction in the plasma clotting time (PCT) (siliconized and plastic) as compared to non-pregnant controls. This hypercoagulability was entirely due to an increased activity of platelet factor 3, since a comparable reduction in the clotting time was obtained when the washed platelets from these animals were resuspended in a standard platelet-poor plasma. In contrast to this, when the platelets in the original plasma were replaced by a phospholipid suspension, the clotting time in plastic but not in glass, was prolonged in pregnant rats, suggesting a decreased activity of the contact system. In addition, the pregnant rats exhibited a marked increased susceptibility of platelets to thrombin and to ADP-induced aggregation.In 6 pregnant women and in 9 women taking contraceptives, a highly significant in vitro hypercoagulability was also present, since the PCT was decreased 26% and 22%, respectively, as compared to the 14 controls. This hypercoagulability appeared to be entirely due to the increased activity of platelet factor 3 as in rat. However, the clear-cut increased susceptibility of platelets to thrombin and ADP-induced aggregation noted in the pregnant rats was not obtained in either the pregnant women or in the women taking contraceptives.
Collapse
|
18
|
Abstract
SummaryPhenylbutazone, oxyphenbutazone, and sulfinpyrazone were equally effective at the dosage of 100 mg/kg (per os) in inhibiting thrombin- and ADP-induced platelet aggregation in hyperlipemic rats, and in preventing the development of thrombosis initiated by the intravenous injection of an endotoxin. Despite a slight anticoagulant effect of these substances, their antithrombotic activity appears to be due mostly to inhibition of platelet aggregation.Thrombosis in hyperlipemic rats could also be prevented by a dicoumarol derivative, acenocoumarin, which only inhibits coagulation. Therefore, both platelet aggregation and fibrin formation appear to be essential for the occurrence of large thrombi under these conditions. Nevertheless, although acenocoumarin has no direct effect on platelet aggregation, it could indirectly affect this phenomenon by blocking the formation of thrombin, which is suspected of being the agent responsible for initiating thrombosis in hyperlipemic rats.Low doses of phenylbutazone and acenocoumarin, in condition, which when given alone were ineffective in inhibiting thrombosis, could decrease the severity of thrombosis by 33%. The substance GP45840, when added in vitro to platelet-rich plasma as well as given per os to hyperlipemic rats, was no more effective than sulfinpyrazone in inhibiting platelet aggregation. Nevertheless, this substance was significantly more efficient in reducing thrombosis than was sulfinpyrazone, apparently through some additional anticoagulant activity. The results of these experiments suggest that it could be beneficial to affect both coagulation and platelet aggregation in order to satisfactorily prevent thrombosis.
Collapse
|
19
|
Perrier R, Pirog A, Jaffredo M, Gaitan J, Catargi B, Renaud S, Raoux M, Lang J. Bioelectronic organ-based sensor for microfluidic real-time analysis of the demand in insulin. Biosens Bioelectron 2018; 117:253-259. [PMID: 29909196 DOI: 10.1016/j.bios.2018.06.015] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2018] [Revised: 06/04/2018] [Accepted: 06/06/2018] [Indexed: 12/31/2022]
Abstract
On-line and real-time analysis of micro-organ activity permits to use the endogenous analytical power of cellular signal transduction algorithms as biosensors. We have developed here such a sensor using only a few pancreatic endocrine islets and the avoidance of transgenes or chemical probes reduces bias and procures general usage. Nutrient and hormone-induced changes in islet ion fluxes through channels provide the first integrative read-out of micro-organ activity. Using extracellular electrodes we captured this read-out non-invasively as slow potentials which reflect glucose concentration-dependent (3-15 mM) micro-organ activation and coupling. Custom-made PDMS-based microfluidics with platinum black micro-electrode arrays required only some tens of islets and functioned at flow rates of 1-10 µl/min which are compatible with microdialysis. We developed hardware solutions for on-line real-time analysis on a reconfigurable Field-Programmable Gate Array (FPGA) that offered resource-efficient architecture and storage of intermediary processing stages. Moreover, real-time adaptive and reconfigurable algorithms accounted for signal disparities and noise distribution. Based on islet slow potentials, this integrated set-up allowed within less than 40 μs the discrimination and precise automatic ranking of small increases (2 mM steps) of glucose concentrations in real time and within the physiological glucose range. This approach shall permit further development in continuous monitoring of the demand for insulin in type 1 diabetes as well as monitoring of organs-on-chip or maturation of stem-cell derived islets.
Collapse
Affiliation(s)
- R Perrier
- Laboratoire de Chimie et Biologie des Membranes et des Nano-Objets (CBMN), UMR CNRS 5248, Univ. Bordeaux, 18 Av Geoffroy St Hilaire, 33600 Pessac, France
| | - A Pirog
- Laboratoire d'Intégration du Matériau au Système (IMS), UMR CNRS 5218, Univ. Bordeaux, Bordeaux INP, 33400 Talence, France
| | - M Jaffredo
- Laboratoire de Chimie et Biologie des Membranes et des Nano-Objets (CBMN), UMR CNRS 5248, Univ. Bordeaux, 18 Av Geoffroy St Hilaire, 33600 Pessac, France
| | - J Gaitan
- Laboratoire de Chimie et Biologie des Membranes et des Nano-Objets (CBMN), UMR CNRS 5248, Univ. Bordeaux, 18 Av Geoffroy St Hilaire, 33600 Pessac, France
| | - B Catargi
- Laboratoire de Chimie et Biologie des Membranes et des Nano-Objets (CBMN), UMR CNRS 5248, Univ. Bordeaux, 18 Av Geoffroy St Hilaire, 33600 Pessac, France; Hôpital St André, Bordeaux University Hospital, Univ. Bordeaux, 1 rue Jean Burguet, 33000 Bordeaux, France
| | - S Renaud
- Laboratoire d'Intégration du Matériau au Système (IMS), UMR CNRS 5218, Univ. Bordeaux, Bordeaux INP, 33400 Talence, France
| | - M Raoux
- Laboratoire de Chimie et Biologie des Membranes et des Nano-Objets (CBMN), UMR CNRS 5248, Univ. Bordeaux, 18 Av Geoffroy St Hilaire, 33600 Pessac, France
| | - J Lang
- Laboratoire de Chimie et Biologie des Membranes et des Nano-Objets (CBMN), UMR CNRS 5248, Univ. Bordeaux, 18 Av Geoffroy St Hilaire, 33600 Pessac, France.
| |
Collapse
|
20
|
Reeb J, Olland A, Renaud S, Kindo M, Santelmo N, Massard G, Falcoz PE. Principi e indicazioni dell’assistenza circolatoria e respiratoria extracorporea in chirurgia toracica. EMC - Tecniche Chirurgiche - Chirurgia Generale 2017. [PMCID: PMC7164803 DOI: 10.1016/s1636-5577(17)82113-1] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
In origine, l’extracorporeal membrane oxygenation (ECMO) era una tecnica di assistenza respiratoria che utilizzava uno scambiatore gassoso a membrana. Per estensione, l’ECMO è diventata una tecnica respiratoria e cardiopolmonare utilizzata in caso di deficit respiratorio e/o cardiaco nell’attesa della restaurazione della funzione deficitaria o di un eventuale trapianto. Il supporto emodinamico può essere parziale o totale. Gli accessi vascolari possono essere periferici o centrali. Questo tipo di assistenza utilizza il concetto di circolazione extracorporea (CEC) sanguigna che in epoca moderna si è estesa con l’utilizzo di polmoni artificiali a membrana. Il circuito di base è semplice e comprende una pompa, un ossigenatore (che permette al sangue di caricarsi di O2 e di eliminare CO2) e delle vie d’accesso (una di drenaggio e una di reinfusione). La sua attuazione è facile, veloce e può essere avviata al letto del malato. Il miglioramento delle attrezzature, una migliore conoscenza delle tecniche e delle indicazioni, e le politiche di salute pubblica hanno reso popolare questa tecnica. Alcuni centri di chirurgia toracica la utilizzano di routine come assistenza alla realizzazione di un intervento terapeutico (soprattutto trapianto) assieme a team di rianimazione per il trattamento della sindrome da distress respiratorio acuto. Nel quadro della malattia polmonare dell’adulto, l’idea principale è quella di sviluppare il concetto di strategia minimalista con l’uso di una CEC adiuvante parziale – più che sostitutiva totale – che permetterebbe il recupero metabolico ad integrum del paziente. Nei prossimi anni, i progressi della tecnologia e dell’ingegneria così come le conoscenze approfondite permetteranno il miglioramento della prognosi dei pazienti colpiti da deficit respiratorio sotto assistenza meccanica.
Collapse
Affiliation(s)
- J. Reeb
- Service de chirurgie thoracique, Groupe de transplantation pulmonaire, Nouvel Hôpital civil, Hôpitaux universitaires de Strasbourg, 1, place de l’Hôpital, 67100 Strasbourg, France
- The Toronto Lung Transplant Program, Toronto General Hospital, University Health Network, 200, Elizabeth Street, Toronto, ON, M5G 2C4, Canada
| | - A. Olland
- Service de chirurgie thoracique, Groupe de transplantation pulmonaire, Nouvel Hôpital civil, Hôpitaux universitaires de Strasbourg, 1, place de l’Hôpital, 67100 Strasbourg, France
| | - S. Renaud
- Service de chirurgie thoracique, Groupe de transplantation pulmonaire, Nouvel Hôpital civil, Hôpitaux universitaires de Strasbourg, 1, place de l’Hôpital, 67100 Strasbourg, France
| | - M. Kindo
- Service de chirurgie cardiovasculaire, Nouvel Hôpital civil, Hôpitaux universitaires de Strasbourg, 1, place de l’Hôpital, 67100 Strasbourg, France
| | - N. Santelmo
- Service de chirurgie thoracique, Groupe de transplantation pulmonaire, Nouvel Hôpital civil, Hôpitaux universitaires de Strasbourg, 1, place de l’Hôpital, 67100 Strasbourg, France
| | - G. Massard
- Service de chirurgie thoracique, Groupe de transplantation pulmonaire, Nouvel Hôpital civil, Hôpitaux universitaires de Strasbourg, 1, place de l’Hôpital, 67100 Strasbourg, France
| | - P.-E. Falcoz
- Service de chirurgie thoracique, Groupe de transplantation pulmonaire, Nouvel Hôpital civil, Hôpitaux universitaires de Strasbourg, 1, place de l’Hôpital, 67100 Strasbourg, France
| |
Collapse
|
21
|
Désert R, Rohart F, Canal F, Sicard M, Desille M, Renaud S, Turlin B, Bellaud P, Perret C, Clément B, Lê Cao KA, Musso O. Human hepatocellular carcinomas with a periportal phenotype have the lowest potential for early recurrence after curative resection. Hepatology 2017; 66:1502-1518. [PMID: 28498607 DOI: 10.1002/hep.29254] [Citation(s) in RCA: 75] [Impact Index Per Article: 10.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/26/2017] [Revised: 04/03/2017] [Accepted: 05/03/2017] [Indexed: 12/25/2022]
Abstract
UNLABELLED Hepatocellular carcinomas (HCCs) exhibit a diversity of molecular phenotypes, raising major challenges in clinical management. HCCs detected by surveillance programs at an early stage are candidates for potentially curative therapies (local ablation, resection, or transplantation). In the long term, transplantation provides the lowest recurrence rates. Treatment allocation is based on tumor number, size, vascular invasion, performance status, functional liver reserve, and the prediction of early (<2 years) recurrence, which reflects the intrinsic aggressiveness of the tumor. Well-differentiated, potentially low-aggressiveness tumors form the heterogeneous molecular class of nonproliferative HCCs, characterized by an approximate 50% β-catenin mutation rate. To define the clinical, pathological, and molecular features and the outcome of nonproliferative HCCs, we constructed a 1,133-HCC transcriptomic metadata set and validated findings in a publically available 210-HCC RNA sequencing set. We show that nonproliferative HCCs preserve the zonation program that distributes metabolic functions along the portocentral axis in normal liver. More precisely, we identified two well-differentiated, nonproliferation subclasses, namely periportal-type (wild-type β-catenin) and perivenous-type (mutant β-catenin), which expressed negatively correlated gene networks. The new periportal-type subclass represented 29% of all HCCs; expressed a hepatocyte nuclear factor 4A-driven gene network, which was down-regulated in mouse hepatocyte nuclear factor 4A knockout mice; were early-stage tumors by Barcelona Clinic Liver Cancer, Cancer of the Liver Italian Program, and tumor-node-metastasis staging systems; had no macrovascular invasion; and showed the lowest metastasis-specific gene expression levels and TP53 mutation rates. Also, we identified an eight-gene periportal-type HCC signature, which was independently associated with the highest 2-year recurrence-free survival by multivariate analyses in two independent cohorts of 247 and 210 patients. CONCLUSION Well-differentiated HCCs display mutually exclusive periportal or perivenous zonation programs. Among all HCCs, periportal-type tumors have the lowest intrinsic potential for early recurrence after curative resection. (Hepatology 2017;66:1502-1518).
Collapse
Affiliation(s)
- Romain Désert
- INSERM, INRA, Univ Rennes, CHU Rennes, Nutrition Metabolisms and Cancer (NuMeCan), CRB-Santé, Biosit, Biogenouest, UBL, Rennes, France
| | - Florian Rohart
- Diamantina Institute and Translational Research Institute, The University of Queensland, Brisbane, QLD, Australia
| | - Frédéric Canal
- INSERM, CNRS, Université de Paris Descartes, Sorbonne Paris Cité, Institut Cochin, Paris, France
| | - Marie Sicard
- INSERM, INRA, Univ Rennes, CHU Rennes, Nutrition Metabolisms and Cancer (NuMeCan), CRB-Santé, Biosit, Biogenouest, UBL, Rennes, France
| | - Mireille Desille
- INSERM, INRA, Univ Rennes, CHU Rennes, Nutrition Metabolisms and Cancer (NuMeCan), CRB-Santé, Biosit, Biogenouest, UBL, Rennes, France
| | - Stéphanie Renaud
- INSERM, INRA, Univ Rennes, CHU Rennes, Nutrition Metabolisms and Cancer (NuMeCan), CRB-Santé, Biosit, Biogenouest, UBL, Rennes, France
| | - Bruno Turlin
- INSERM, INRA, Univ Rennes, CHU Rennes, Nutrition Metabolisms and Cancer (NuMeCan), CRB-Santé, Biosit, Biogenouest, UBL, Rennes, France
| | - Pascale Bellaud
- INSERM, INRA, Univ Rennes, CHU Rennes, Nutrition Metabolisms and Cancer (NuMeCan), CRB-Santé, Biosit, Biogenouest, UBL, Rennes, France
| | - Christine Perret
- INSERM, CNRS, Université de Paris Descartes, Sorbonne Paris Cité, Institut Cochin, Paris, France
| | - Bruno Clément
- INSERM, INRA, Univ Rennes, CHU Rennes, Nutrition Metabolisms and Cancer (NuMeCan), CRB-Santé, Biosit, Biogenouest, UBL, Rennes, France
| | - Kim-Anh Lê Cao
- Diamantina Institute and Translational Research Institute, The University of Queensland, Brisbane, QLD, Australia
| | - Orlando Musso
- INSERM, INRA, Univ Rennes, CHU Rennes, Nutrition Metabolisms and Cancer (NuMeCan), CRB-Santé, Biosit, Biogenouest, UBL, Rennes, France
| |
Collapse
|
22
|
Guerrera F, Renaud S, Santelmo N, Evangelista A, Lyberis P, Mazzella A, Olland A, Bora G, Falcoz P, Filosso PL, Ruffini E, Oliaro A, Massard G. F-015MINIMALLY INVASIVE SURGICAL APPROACHES FOR THE TREATMENT OF NON-THYMOMATOUS MYASTHENIA GRAVIS: A COMPARATIVE PROPENSITY-SCORE ADJUSTED MULTICENTRE STUDY. Interact Cardiovasc Thorac Surg 2017. [DOI: 10.1093/icvts/ivx280.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
23
|
Mora C, Reboul P, Vernier L, Renaud S, Cariou S, Prelipcean C, Vecina F, Moranne O. Diarrhée chronique inexpliquée chez un patient ayant eu une greffe de rein : mycophénolate mofétil ou cryptosporidiose ? Nephrol Ther 2017. [DOI: 10.1016/j.nephro.2017.08.334] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
24
|
Désert R, Rohart F, Canal F, Sicard M, Desille M, Renaud S, Turlin B, Bellaud P, Perret C, Clément B, Lê Cao KA, Musso O. Human hepatocellular carcinomas with a periportal phenotype have the lowest potential for early recurrence after curative resection. Hepatology 2017. [PMID: 28498607 DOI: 10.1002/hep.29254.] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
Hepatocellular carcinomas (HCCs) exhibit a diversity of molecular phenotypes, raising major challenges in clinical management. HCCs detected by surveillance programs at an early stage are candidates for potentially curative therapies (local ablation, resection, or transplantation). In the long term, transplantation provides the lowest recurrence rates. Treatment allocation is based on tumor number, size, vascular invasion, performance status, functional liver reserve, and the prediction of early (<2 years) recurrence, which reflects the intrinsic aggressiveness of the tumor. Well-differentiated, potentially low-aggressiveness tumors form the heterogeneous molecular class of nonproliferative HCCs, characterized by an approximate 50% β-catenin mutation rate. To define the clinical, pathological, and molecular features and the outcome of nonproliferative HCCs, we constructed a 1,133-HCC transcriptomic metadata set and validated findings in a publically available 210-HCC RNA sequencing set. We show that nonproliferative HCCs preserve the zonation program that distributes metabolic functions along the portocentral axis in normal liver. More precisely, we identified two well-differentiated, nonproliferation subclasses, namely periportal-type (wild-type β-catenin) and perivenous-type (mutant β-catenin), which expressed negatively correlated gene networks. The new periportal-type subclass represented 29% of all HCCs; expressed a hepatocyte nuclear factor 4A-driven gene network, which was down-regulated in mouse hepatocyte nuclear factor 4A knockout mice; were early-stage tumors by Barcelona Clinic Liver Cancer, Cancer of the Liver Italian Program, and tumor-node-metastasis staging systems; had no macrovascular invasion; and showed the lowest metastasis-specific gene expression levels and TP53 mutation rates. Also, we identified an eight-gene periportal-type HCC signature, which was independently associated with the highest 2-year recurrence-free survival by multivariate analyses in two independent cohorts of 247 and 210 patients. CONCLUSION Well-differentiated HCCs display mutually exclusive periportal or perivenous zonation programs. Among all HCCs, periportal-type tumors have the lowest intrinsic potential for early recurrence after curative resection. (Hepatology 2017;66:1502-1518).
Collapse
Affiliation(s)
- Romain Désert
- INSERM, INRA, Univ Rennes, CHU Rennes, Nutrition Metabolisms and Cancer (NuMeCan), CRB-Santé, Biosit, Biogenouest, UBL, Rennes, France
| | - Florian Rohart
- Diamantina Institute and Translational Research Institute, The University of Queensland, Brisbane, QLD, Australia
| | - Frédéric Canal
- INSERM, CNRS, Université de Paris Descartes, Sorbonne Paris Cité, Institut Cochin, Paris, France
| | - Marie Sicard
- INSERM, INRA, Univ Rennes, CHU Rennes, Nutrition Metabolisms and Cancer (NuMeCan), CRB-Santé, Biosit, Biogenouest, UBL, Rennes, France
| | - Mireille Desille
- INSERM, INRA, Univ Rennes, CHU Rennes, Nutrition Metabolisms and Cancer (NuMeCan), CRB-Santé, Biosit, Biogenouest, UBL, Rennes, France
| | - Stéphanie Renaud
- INSERM, INRA, Univ Rennes, CHU Rennes, Nutrition Metabolisms and Cancer (NuMeCan), CRB-Santé, Biosit, Biogenouest, UBL, Rennes, France
| | - Bruno Turlin
- INSERM, INRA, Univ Rennes, CHU Rennes, Nutrition Metabolisms and Cancer (NuMeCan), CRB-Santé, Biosit, Biogenouest, UBL, Rennes, France
| | - Pascale Bellaud
- INSERM, INRA, Univ Rennes, CHU Rennes, Nutrition Metabolisms and Cancer (NuMeCan), CRB-Santé, Biosit, Biogenouest, UBL, Rennes, France
| | - Christine Perret
- INSERM, CNRS, Université de Paris Descartes, Sorbonne Paris Cité, Institut Cochin, Paris, France
| | - Bruno Clément
- INSERM, INRA, Univ Rennes, CHU Rennes, Nutrition Metabolisms and Cancer (NuMeCan), CRB-Santé, Biosit, Biogenouest, UBL, Rennes, France
| | - Kim-Anh Lê Cao
- Diamantina Institute and Translational Research Institute, The University of Queensland, Brisbane, QLD, Australia
| | - Orlando Musso
- INSERM, INRA, Univ Rennes, CHU Rennes, Nutrition Metabolisms and Cancer (NuMeCan), CRB-Santé, Biosit, Biogenouest, UBL, Rennes, France
| |
Collapse
|
25
|
Reboul P, Roux-Marson C, Pinzani V, Olivier V, Cariou S, Renaud S, Vecina F, Prelipcean C, Moranne O, Bengler C, Lefrant JY, Boyer JC. Les formes graves d’acidose lactique associée à la metformine (ALAM) : le risque existe aussi pour les patients avec DFG > 60 mL/min à l’occasion d’une insuffisance rénale aiguë (IRA). Toxicologie Analytique et Clinique 2017. [DOI: 10.1016/j.toxac.2017.03.111] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
26
|
Renaud S, Fiche M, Stravodimou A, Scabia V, Dormoy VM, Galmiche Rindisbacher M, Brisken C, Mermod N, Zaman K. Abstract P2-05-11: miR363-3p mediates maintenance and resistance of breast cancer stem cells (BCSC). Cancer Res 2017. [DOI: 10.1158/1538-7445.sabcs16-p2-05-11] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background
BCSC are considered to be involved in the recurrence of breast cancer and its resistance to the systemic therapies. Their detection and targeting remain challenging.
Patients and methods:
The study was conducted in vitro, in xenografted immunecompromised mice and samples of 38 patients with early stage BC having biopsies and blood samples before and after anthraycycline + taxane-based neoadjuvant chemotherapy (NAC). All patients gave written informed consent before inclusion. 1) MCF7 cells grown as mammospheres (MS) for BCSC enrichment were treated with 5FU or paclitaxel (Pac) to select chemo-resistant BCSC. miRNA microarray was performed to identify specific miRNAs for chemo-resistant BCSC. The results were compared to miRNAs found in immortalized non-tumorigenic MCF10A cells to exclude miRNAs related to normal stem cells. 2) The correlation between the most highly expressed miRNA and the BCSC was confirmed by RT-qPCR in ALDH+ and ALDH- cells sorted from MCF7 and MDA-MB-231 cells by flow cytometry. 3) The impact of the miRNA on MS and colony development was assessed by up- and down-regulating its expression. MCF7 cells transfected with ectopic expression of miRNA, anti-miRNA or miRNA control were grown in MS before being injected in mice using a mouse INtraDuctal xenograft Model (MIND). In vivo tumor growth was assessed by luciferase imaging, then measured and quantified with human GAPDH ex vivo at 6 weeks. 4) The miRNA was quantified by RT-qPCR in tumor samples and sera of the patients before and after treatment, and its levels were correlated with pathological complete response and patients' outcomes.
Results:
379 miRNAs out of 2006 were altered in chemo-resistant versus untreated MCF7 MS. Thirteen were specific for 5FU and 5 for Pac. Three were common for both drugs. Of these, miR-363-3p was overexpressed specifically in BCSC-enriched chemo-resistant MCF7 cells and all the other tested BC cell lines, but not in non-tumorigenic MCF10A cells. Compared to adherent MCF7 cells, miR-363-3p was 12-, 60-, and 10-folds more expressed in BCSC-enriched MS treated with 5FU, Pac, or without treatment, respectively. miR-363-3p was 20- and 100-folds higher in ALDH+ compared to ALDH- in MCF7 and MDA-MB-231 cells. Anti-miR-363-3p reduced MS size and decreased their number 50%. A significant decrease of the number of colonies was also observed in soft agar. Consistently, miR-363-3p downregulation decreased tumor growth and metastasis by MCF7 cells transplanted in mice. In patients' sera with lower baseline level (n=15), miR-363-3p appeared decreased upon NAC. Patients with high miR-363-3p serum levels (n=22) had more risk to maintain higher level after chemotherapy. Triple-negative and HER2+ BC were more frequent in this second group. No significant difference was observed in term of pCR between the 2 groups. However 3 patients relapsed with distant metastases and all were in the second group with high baseline level and no decrease after NAC.
Conclusions:
miR363-3p appeared to be a mediator of chemo-resistant BCSC. Its measurement in the serum of BC patients may predict resistance to neo-/adjuvant chemotherapy and higher risk of distant recurrence. Further investigations are warranted to confirm its role as biomarker and potential therapeutic target against BCSC.
Citation Format: Renaud S, Fiche M, Stravodimou A, Scabia V, Dormoy VM, Galmiche Rindisbacher M, Brisken C, Mermod N, Zaman K. miR363-3p mediates maintenance and resistance of breast cancer stem cells (BCSC) [abstract]. In: Proceedings of the 2016 San Antonio Breast Cancer Symposium; 2016 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2017;77(4 Suppl):Abstract nr P2-05-11.
Collapse
Affiliation(s)
- S Renaud
- Laboratory of Molecular Biotechnology, University of Lausanne, Lausanne, Switzerland; University Hospital CHUV, Lausanne, Switzerland; Breast Center, University Hospital CHUV, Lausanne, Switzerland; Ecole Polytechnique Fédérale (EPFL), Switzerland; CHU Maison Blanche, University of Reims Champagne-Ardenne (URCA), France
| | - M Fiche
- Laboratory of Molecular Biotechnology, University of Lausanne, Lausanne, Switzerland; University Hospital CHUV, Lausanne, Switzerland; Breast Center, University Hospital CHUV, Lausanne, Switzerland; Ecole Polytechnique Fédérale (EPFL), Switzerland; CHU Maison Blanche, University of Reims Champagne-Ardenne (URCA), France
| | - A Stravodimou
- Laboratory of Molecular Biotechnology, University of Lausanne, Lausanne, Switzerland; University Hospital CHUV, Lausanne, Switzerland; Breast Center, University Hospital CHUV, Lausanne, Switzerland; Ecole Polytechnique Fédérale (EPFL), Switzerland; CHU Maison Blanche, University of Reims Champagne-Ardenne (URCA), France
| | - V Scabia
- Laboratory of Molecular Biotechnology, University of Lausanne, Lausanne, Switzerland; University Hospital CHUV, Lausanne, Switzerland; Breast Center, University Hospital CHUV, Lausanne, Switzerland; Ecole Polytechnique Fédérale (EPFL), Switzerland; CHU Maison Blanche, University of Reims Champagne-Ardenne (URCA), France
| | - VM Dormoy
- Laboratory of Molecular Biotechnology, University of Lausanne, Lausanne, Switzerland; University Hospital CHUV, Lausanne, Switzerland; Breast Center, University Hospital CHUV, Lausanne, Switzerland; Ecole Polytechnique Fédérale (EPFL), Switzerland; CHU Maison Blanche, University of Reims Champagne-Ardenne (URCA), France
| | - M Galmiche Rindisbacher
- Laboratory of Molecular Biotechnology, University of Lausanne, Lausanne, Switzerland; University Hospital CHUV, Lausanne, Switzerland; Breast Center, University Hospital CHUV, Lausanne, Switzerland; Ecole Polytechnique Fédérale (EPFL), Switzerland; CHU Maison Blanche, University of Reims Champagne-Ardenne (URCA), France
| | - C Brisken
- Laboratory of Molecular Biotechnology, University of Lausanne, Lausanne, Switzerland; University Hospital CHUV, Lausanne, Switzerland; Breast Center, University Hospital CHUV, Lausanne, Switzerland; Ecole Polytechnique Fédérale (EPFL), Switzerland; CHU Maison Blanche, University of Reims Champagne-Ardenne (URCA), France
| | - N Mermod
- Laboratory of Molecular Biotechnology, University of Lausanne, Lausanne, Switzerland; University Hospital CHUV, Lausanne, Switzerland; Breast Center, University Hospital CHUV, Lausanne, Switzerland; Ecole Polytechnique Fédérale (EPFL), Switzerland; CHU Maison Blanche, University of Reims Champagne-Ardenne (URCA), France
| | - K Zaman
- Laboratory of Molecular Biotechnology, University of Lausanne, Lausanne, Switzerland; University Hospital CHUV, Lausanne, Switzerland; Breast Center, University Hospital CHUV, Lausanne, Switzerland; Ecole Polytechnique Fédérale (EPFL), Switzerland; CHU Maison Blanche, University of Reims Champagne-Ardenne (URCA), France
| |
Collapse
|
27
|
Guerrera F, Renaud S, Tabbo F, Voegeli' A, Filosso P, Legrain M, Beau-Faller M, Ruffini E, Falcoz P, Inghirami G, Oliaro A, Massard G. F-036EPIDERMAL GROWTH FACTOR RECEPTOR MUTATIONS ARE LINKED TO SKIP N2 LYMPH NODE METASTASIS IN RESECTED NON-SMALL CELL LUNG CANCER ADENOCARCINOMAS. Interact Cardiovasc Thorac Surg 2016. [DOI: 10.1093/icvts/ivw260.36] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
28
|
Désert R, Mebarki S, Desille M, Sicard M, Lavergne E, Renaud S, Bergeat D, Sulpice L, Perret C, Turlin B, Clément B, Musso O. "Fibrous nests" in human hepatocellular carcinoma express a Wnt-induced gene signature associated with poor clinical outcome. Int J Biochem Cell Biol 2016; 81:195-207. [PMID: 27545991 DOI: 10.1016/j.biocel.2016.08.017] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2015] [Revised: 08/01/2016] [Accepted: 08/17/2016] [Indexed: 12/12/2022]
Abstract
Hepatocellular carcinoma (HCC) is the 3rd cause of cancer-related death worldwide. Most cases arise in a background of chronic inflammation, extracellular matrix (ECM) remodeling, severe fibrosis and stem/progenitor cell amplification. Although HCCs are soft cellular tumors, they may contain fibrous nests within the tumor mass. Thus, the aim of this study was to explore cancer cell phenotypes in fibrous nests. Combined anatomic pathology, tissue microarray and real-time PCR analyses revealed that HCCs (n=82) containing fibrous nests were poorly differentiated, expressed Wnt pathway components and target genes, as well as markers of stem/progenitor cells, such as CD44, LGR5 and SOX9. Consistently, in severe liver fibroses (n=66) and in HCCs containing fibrous nests, weighted correlation analysis revealed a gene network including the myofibroblast marker ACTA2, the basement membrane components COL4A1 and LAMC1, the Wnt pathway members FZD1; FZD7; WNT2; LEF1; DKK1 and the Secreted Frizzled Related Proteins (SFRPs) 1; 2 and 5. Moreover, unbiased random survival forest analysis of a transcriptomic dataset of 247 HCC patients revealed high DKK1, COL4A1, SFRP1 and LAMC1 to be associated with advanced tumor staging as well as with bad overall and disease-free survival. In vitro, these genes were upregulated in liver cancer stem/progenitor cells upon Wnt-induced mesenchymal commitment and myofibroblast differentiation. In conclusion, fibrous nests express Wnt target genes, as well as markers of cancer stem cells and mesenchymal commitment. Fibrous nests embody the specific microenvironment of the cancer stem cell niche and can be detected by routine anatomic pathology analyses.
Collapse
Affiliation(s)
- Romain Désert
- Inserm, UMR991, Liver Metabolisms and Cancer, Rennes, France; Université de Rennes 1, F-35043 Rennes, France.
| | - Sihem Mebarki
- Inserm, UMR991, Liver Metabolisms and Cancer, Rennes, France; Université de Rennes 1, F-35043 Rennes, France.
| | - Mireille Desille
- Inserm, UMR991, Liver Metabolisms and Cancer, Rennes, France; Université de Rennes 1, F-35043 Rennes, France; CHU Rennes, Centre de Ressources Biologiques Santé BB-0033-00056, Rennes, France.
| | - Marie Sicard
- Inserm, UMR991, Liver Metabolisms and Cancer, Rennes, France; Université de Rennes 1, F-35043 Rennes, France.
| | - Elise Lavergne
- Inserm, UMR991, Liver Metabolisms and Cancer, Rennes, France; Université de Rennes 1, F-35043 Rennes, France.
| | - Stéphanie Renaud
- Inserm, UMR991, Liver Metabolisms and Cancer, Rennes, France; Université de Rennes 1, F-35043 Rennes, France.
| | - Damien Bergeat
- Inserm, UMR991, Liver Metabolisms and Cancer, Rennes, France; Université de Rennes 1, F-35043 Rennes, France; CHU de Rennes, Dept. of Gastrointestinal and Hepatobiliary Surgery, Rennes, France.
| | - Laurent Sulpice
- Inserm, UMR991, Liver Metabolisms and Cancer, Rennes, France; Université de Rennes 1, F-35043 Rennes, France; CHU de Rennes, Dept. of Gastrointestinal and Hepatobiliary Surgery, Rennes, France.
| | - Christine Perret
- Inserm, U1016, Institut Cochin, Paris, France; Cnrs, UMR8104, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
| | - Bruno Turlin
- Inserm, UMR991, Liver Metabolisms and Cancer, Rennes, France; Université de Rennes 1, F-35043 Rennes, France; CHU Rennes, Centre de Ressources Biologiques Santé BB-0033-00056, Rennes, France.
| | - Bruno Clément
- Inserm, UMR991, Liver Metabolisms and Cancer, Rennes, France; Université de Rennes 1, F-35043 Rennes, France.
| | - Orlando Musso
- Inserm, UMR991, Liver Metabolisms and Cancer, Rennes, France; Université de Rennes 1, F-35043 Rennes, France.
| |
Collapse
|
29
|
Renaud S, Santelmo N. [Robotic-assisted thoracic surgery: for or against?]. Rev Mal Respir 2016; 33:199-201. [PMID: 27068871 DOI: 10.1016/j.rmr.2016.03.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Affiliation(s)
- S Renaud
- Service de chirurgie thoracique, Nouvel Hôpital Civil, hôpitaux universitaires de Strasbourg, 1, place de l'Hôpital, 67091 Strasbourg cedex, France; EA 3430 « progression tumorale et micro-environnement ; approches translationnelles et épidémiologie », université de Strasbourg, bâtiment Inserm 3, avenue Molière, 67200 Strasbourg, France
| | - N Santelmo
- Service de chirurgie thoracique, Nouvel Hôpital Civil, hôpitaux universitaires de Strasbourg, 1, place de l'Hôpital, 67091 Strasbourg cedex, France.
| |
Collapse
|
30
|
Corcé V, Gouin SG, Renaud S, Gaboriau F, Deniaud D. Recent advances in cancer treatment by iron chelators. Bioorg Med Chem Lett 2015; 26:251-256. [PMID: 26684852 DOI: 10.1016/j.bmcl.2015.11.094] [Citation(s) in RCA: 46] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2015] [Revised: 11/12/2015] [Accepted: 11/25/2015] [Indexed: 01/19/2023]
Abstract
The development of new therapeutic alternatives for cancers is a major public health priority. Among the more promising approaches, the iron depletion strategy based on metal chelation in the tumoral environment has been particularly studied in recent decades. After a short description of the importance of iron for cancer cell proliferation, we will review the different iron chelators developed as potential chemotherapeutics. Finally, the recent efforts to vectorize the chelating agents specifically in the microtumoral environment will be discussed in detail.
Collapse
Affiliation(s)
- Vincent Corcé
- LUNAM Université, CEISAM, Chimie Et Interdisciplinarité, Synthèse, Analyse, Modélisation, UMR CNRS 6230, UFR des Sciences et des Techniques, 2, rue de la Houssinière, BP 92208, 44322 Nantes Cedex 3, France
| | - Sébastien G Gouin
- LUNAM Université, CEISAM, Chimie Et Interdisciplinarité, Synthèse, Analyse, Modélisation, UMR CNRS 6230, UFR des Sciences et des Techniques, 2, rue de la Houssinière, BP 92208, 44322 Nantes Cedex 3, France
| | - Stéphanie Renaud
- INSERM, UMR 991, CHRU Pontchaillou, 35033 Rennes, France; Université de Rennes 1, 35043 Rennes, France
| | - François Gaboriau
- INSERM, UMR 991, CHRU Pontchaillou, 35033 Rennes, France; Université de Rennes 1, 35043 Rennes, France
| | - David Deniaud
- LUNAM Université, CEISAM, Chimie Et Interdisciplinarité, Synthèse, Analyse, Modélisation, UMR CNRS 6230, UFR des Sciences et des Techniques, 2, rue de la Houssinière, BP 92208, 44322 Nantes Cedex 3, France
| |
Collapse
|
31
|
Renaud S, Corcé V, Cannie I, Ropert M, Lepage S, Loréal O, Deniaud D, Gaboriau F. Quilamine HQ1-44, an iron chelator vectorized toward tumor cells by the polyamine transport system, inhibits HCT116 tumor growth without adverse effect. Biochem Pharmacol 2015; 96:179-89. [DOI: 10.1016/j.bcp.2015.06.001] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2015] [Accepted: 06/01/2015] [Indexed: 11/25/2022]
|
32
|
|
33
|
Renaud S, Falcoz PE, Schaeffer M, Beau-Faller M, Romain B, Olland A, Reeb J, Santelmo N, Massard G, Voegeli AC. Prognostic Influence of Mutational Status in Resected Non-Small Cell Lung Cancer: the KRAS G12V Worse Value. Ann Oncol 2015. [DOI: 10.1093/annonc/mdv048.06] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
34
|
Alberti L, Renaud S, Losi L, Leyvraz S, Benhattar J. High expression of hTERT and stemness genes in BORIS/CTCFL positive cells isolated from embryonic cancer cells. PLoS One 2014; 9:e109921. [PMID: 25279549 PMCID: PMC4184884 DOI: 10.1371/journal.pone.0109921] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2014] [Accepted: 09/12/2014] [Indexed: 01/08/2023] Open
Abstract
BORIS/CTCFL is a member of cancer testis antigen family normally expressed in germ cells. In tumors, it is aberrantly expressed although its functions are not completely well-defined. To better understand the functions of BORIS in cancer, we selected the embryonic cancer cells as a model. Using a molecular beacon, which specifically targets BORIS mRNA, we demonstrated that BORIS positive cells are a small subpopulation of tumor cells (3–5% of total). The BORIS-positive cells isolated using BORIS-molecular beacon, expressed higher telomerase hTERT, stem cell (NANOG, OCT4, SOX2) and cancer stem cell marker genes (CD44 and ALDH1) compared to the BORIS-negative tumor cells. In order to define the functional role of BORIS, stable BORIS-depleted embryonic cancer cells were generated. BORIS silencing strongly down-regulated the expression of hTERT, stem cell and cancer stem cell marker genes. Moreover, the BORIS knockdown increased cellular senescence in embryonic cancer cells, revealing a putative role of BORIS in the senescence biological program. Our data indicate an association of BORIS expressing cells subpopulation with the expression of stemness genes, highlighting the critical role played by BORIS in embryonic neoplastic disease.
Collapse
Affiliation(s)
- Loredana Alberti
- Institute of Pathology, Lausanne University Hospital, Lausanne, Switzerland
| | - Stéphanie Renaud
- Institute of Biotechnology, University of Lausanne, Lausanne, Switzerland
| | - Lorena Losi
- Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy
| | - Serge Leyvraz
- Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland
| | - Jean Benhattar
- Institute of Pathology, Lausanne University Hospital, Lausanne, Switzerland
- Biopath Lab, Lausanne, Switzerland
- * E-mail:
| |
Collapse
|
35
|
Renaud S, Romain B, Falcoz PE, Olland A, Santelmo N, Brigand C, Rohr S, Guenot D, Massard G. F-077 * KRAS AND BRAF MUTATIONS ARE PROGNOSTIC BIOMARKERS IN PATIENTS UNDERGOING LUNG METASTASECTOMY OF COLORECTAL CANCER. Interact Cardiovasc Thorac Surg 2014. [DOI: 10.1093/icvts/ivu167.77] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
36
|
Renaud S, Falcoz PE, Alifano M, Olland A, Magdeleinat P, Pagès O, Regnard JF, Massard G. Systematic lymph node dissection in lung metastasectomy of renal cell carcinoma: an 18 years of experience. J Surg Oncol 2014; 109:823-9. [PMID: 24619772 DOI: 10.1002/jso.23593] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2013] [Accepted: 02/11/2014] [Indexed: 01/05/2023]
Abstract
BACKGROUND Pulmonary metastasectomy of renal cell carcinomas (RCC) remains controversial. Thoracic lymph node involvement (LNI) is a known prognostic factor. The aim of our analysis is to evaluate whether patients with LNI, and particularly N2 patients, should be excluded from surgical treatment. METHODS We retrospectively reviewed data from 122 patients who underwent operations at two French thoracic surgery departments between 1993 and 2011 for RCC lung metastases. RESULTS The population consisted of 38 women and 84 men; the average age at time of metastasectomy was 63.3 years (min: 43, max: 82). LNI was identified as a prognostic factor using univariate and multivariate analysis (median survival: 107 months vs. 37 months, P = 0.003; HR = 0.384 (0.179; 0.825), P = 0.01, respectively). Although differences in survival between metastases at the hilar and mediastinal locations were not significant (median survival: 74 months vs. 32 months, respectively, P = 0.75), length of survival time was associated with disease-free interval less than 12 months (median survival: 23 months vs. 94 months, P < 0.0001; HR = 3.081 (1.193; 7.957), P = 0.02). CONCLUSION Although LNI has an adverse effect on survival; long-term survival can be achieved in pN+ patients. Consequently, these patients should not be excluded from surgery. Systematic lymphadenectomy should be performed to obtain more accurate staging and to determine appropriate adjuvant treatment.
Collapse
Affiliation(s)
- S Renaud
- Department of Thoracic Surgery, Nouvel Hôpital Civil, Strasbourg University Hospital, Strasbourg, France
| | | | | | | | | | | | | | | |
Collapse
|
37
|
Corcé V, Renaud S, Cannie I, Julienne K, Gouin SG, Loréal O, Gaboriau F, Deniaud D. Synthesis and Biological Properties of Quilamines II, New Iron Chelators with Antiproliferative Activities. Bioconjug Chem 2014; 25:320-34. [DOI: 10.1021/bc4004734] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Affiliation(s)
- Vincent Corcé
- LUNAM Université, CEISAM, Chimie Et Interdisciplinarité,
Synthèse, Analyse, Modélisation, UMR CNRS 6230, UFR
des Sciences et des Techniques, 2, rue de la Houssinière, BP 92208, 44322 Nantes Cedex 3, France
- INSERM,
UMR 991,
CHRU Pontchaillou, 35033 Rennes, France
- Université de Rennes 1, 35043 Rennes, France
| | - Stéphanie Renaud
- INSERM,
UMR 991,
CHRU Pontchaillou, 35033 Rennes, France
- Université de Rennes 1, 35043 Rennes, France
| | - Isabelle Cannie
- INSERM,
UMR 991,
CHRU Pontchaillou, 35033 Rennes, France
- Université de Rennes 1, 35043 Rennes, France
| | - Karine Julienne
- LUNAM Université, CEISAM, Chimie Et Interdisciplinarité,
Synthèse, Analyse, Modélisation, UMR CNRS 6230, UFR
des Sciences et des Techniques, 2, rue de la Houssinière, BP 92208, 44322 Nantes Cedex 3, France
| | - Sébastien G. Gouin
- LUNAM Université, CEISAM, Chimie Et Interdisciplinarité,
Synthèse, Analyse, Modélisation, UMR CNRS 6230, UFR
des Sciences et des Techniques, 2, rue de la Houssinière, BP 92208, 44322 Nantes Cedex 3, France
| | - Olivier Loréal
- INSERM,
UMR 991,
CHRU Pontchaillou, 35033 Rennes, France
- Université de Rennes 1, 35043 Rennes, France
| | - François Gaboriau
- INSERM,
UMR 991,
CHRU Pontchaillou, 35033 Rennes, France
- Université de Rennes 1, 35043 Rennes, France
| | - David Deniaud
- LUNAM Université, CEISAM, Chimie Et Interdisciplinarité,
Synthèse, Analyse, Modélisation, UMR CNRS 6230, UFR
des Sciences et des Techniques, 2, rue de la Houssinière, BP 92208, 44322 Nantes Cedex 3, France
| |
Collapse
|
38
|
Renaud S, Prim N, Antoni D, Olland A, Santelmo N, Schumacher C, Falcoz PE, Quoix E, Massard G, Noël G. Doit-on traiter différemment les cancers bronchiques non à petites cellules de stade IIIA-N2 en fonction du type d’atteinte ganglionnaire ? Cancer Radiother 2013. [DOI: 10.1016/j.canrad.2013.07.070] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
39
|
Falcoz PE, Vitale L, Renaud S, Reeb J, Olland A, Santelmo N, Massard G. F-043VIDEO-THORACOSCOPIC LOBECTOMIES IN THE EPITHOR® DATABASE: EPIDEMIOLOGICAL ANALYSIS AND COMPARISON WITH THE OPEN TECHNIQUE OVER A 9-YEAR PERIOD. Interact Cardiovasc Thorac Surg 2013. [DOI: 10.1093/icvts/ivt288.43] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
40
|
Renaud S, Santelmo N, Renaud M, Falcoz P, Tranchant C, Massard G. Prise en charge chirurgicale de la myasthénie auto-immune (ou myasthenia gravis). ACTA ACUST UNITED AC 2013. [DOI: 10.1016/s1241-8226(12)59757-4] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
41
|
Renaud S, Hardouin EA, Pisanu B, Chapuis JL. Invasive house mice facing a changing environment on the Sub-Antarctic Guillou Island (Kerguelen Archipelago). J Evol Biol 2013; 26:612-24. [PMID: 23331296 DOI: 10.1111/jeb.12079] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2012] [Revised: 10/16/2012] [Accepted: 11/19/2012] [Indexed: 11/26/2022]
Abstract
Adaptation to new environments is a key feature in evolution promoting divergence in morphological structures under selection. The house mouse (Mus musculus domesticus) introduced on the Sub-Antarctic Guillou Island (Kerguelen Archipelago) had and still has to face environmental conditions that likely shaped the pattern and pace of its insular evolution. Since mouse arrival on the island, probably not more than two centuries ago, ecological conditions dramatically differed from those available to their Western European commensal source populations. In addition, over the last two decades, the plant and animal communities of Guillou Island were considerably modified by the eradication of rabbits, the effects of climate change and the spread of invasive species detrimental to native communities. Under such a changing habitat, the mouse response was investigated using a morphometric quantification of mandible and molar tooth, two morphological structures related to food processing. A marked differentiation of the insular mice compared with their relatives from Western Europe was documented for both mandibles and molar shapes. Moreover, these shapes changed through the 16 years of the record, in agreement with expectations of drift for the molar, but more than expected by chance for the mandible. These results suggest that mice responded to the recent changes in food resources, possibly with a part of plastic variation for the mandible prone to bone remodelling. This pattern exemplifies the intricate interplay of evolution, ecology and plasticity that is a probable key of the success of such an invasive rodent facing pronounced shifts in food resources exploitation under a changing environment.
Collapse
Affiliation(s)
- S Renaud
- Laboratoire de Biométrie et Biologie Evolutive, UMR 5558, CNRS, Université de Lyon, Villeurbanne, France.
| | | | | | | |
Collapse
|
42
|
Tourjman S, Djouini A, Baruch P, Beaulieu S, Bergeron R, Chanut F, Daigneault A, Li L, Purdon S, Renaud S, Villeneuve É. 2120 – Feasibility of the use of the screen for cognitive impairment in psychiatry (SCIP) in a clinical population with adult attention deficit disorder. Eur Psychiatry 2013. [DOI: 10.1016/s0924-9338(13)77010-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
43
|
Corcé V, Morin E, Guihéneuf S, Renault E, Renaud S, Cannie I, Tripier R, Lima LMP, Julienne K, Gouin SG, Loréal O, Deniaud D, Gaboriau F. Polyaminoquinoline Iron Chelators for Vectorization of Antiproliferative Agents: Design, Synthesis, and Validation. Bioconjug Chem 2012; 23:1952-68. [DOI: 10.1021/bc300324c] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Affiliation(s)
- Vincent Corcé
- LUNAM Université, CEISAM,
Chimie Et Interdisciplinarité, Synthèse, Analyse, Modélisation, UMR CNRS 6230, UFR des Sciences et des Techniques,
2, rue de la Houssinière, BP 92208, 44322 NANTES Cedex 3, France
- INSERM, UMR991, CHRU Pontchaillou, 35033 Rennes, France; Université de Rennes1,
35043 Rennes, France
| | - Emmanuelle Morin
- LUNAM Université, CEISAM,
Chimie Et Interdisciplinarité, Synthèse, Analyse, Modélisation, UMR CNRS 6230, UFR des Sciences et des Techniques,
2, rue de la Houssinière, BP 92208, 44322 NANTES Cedex 3, France
| | - Solène Guihéneuf
- LUNAM Université, CEISAM,
Chimie Et Interdisciplinarité, Synthèse, Analyse, Modélisation, UMR CNRS 6230, UFR des Sciences et des Techniques,
2, rue de la Houssinière, BP 92208, 44322 NANTES Cedex 3, France
| | - Eric Renault
- LUNAM Université, CEISAM,
Chimie Et Interdisciplinarité, Synthèse, Analyse, Modélisation, UMR CNRS 6230, UFR des Sciences et des Techniques,
2, rue de la Houssinière, BP 92208, 44322 NANTES Cedex 3, France
| | - Stéphanie Renaud
- INSERM, UMR991, CHRU Pontchaillou, 35033 Rennes, France; Université de Rennes1,
35043 Rennes, France
| | - Isabelle Cannie
- INSERM, UMR991, CHRU Pontchaillou, 35033 Rennes, France; Université de Rennes1,
35043 Rennes, France
| | - Raphaël Tripier
- CNRS, UMR 6521, Université de Brest, Laboratoire
de Chimie, Electrochimie
Moléculaires et Chimie Analytique, 6 Avenue Victor Le Gorgeu,
29200 Brest, France
| | - Luís M. P. Lima
- CNRS, UMR 6521, Université de Brest, Laboratoire
de Chimie, Electrochimie
Moléculaires et Chimie Analytique, 6 Avenue Victor Le Gorgeu,
29200 Brest, France
| | - Karine Julienne
- LUNAM Université, CEISAM,
Chimie Et Interdisciplinarité, Synthèse, Analyse, Modélisation, UMR CNRS 6230, UFR des Sciences et des Techniques,
2, rue de la Houssinière, BP 92208, 44322 NANTES Cedex 3, France
| | - Sébastien G. Gouin
- LUNAM Université, CEISAM,
Chimie Et Interdisciplinarité, Synthèse, Analyse, Modélisation, UMR CNRS 6230, UFR des Sciences et des Techniques,
2, rue de la Houssinière, BP 92208, 44322 NANTES Cedex 3, France
| | - Olivier Loréal
- INSERM, UMR991, CHRU Pontchaillou, 35033 Rennes, France; Université de Rennes1,
35043 Rennes, France
| | - David Deniaud
- LUNAM Université, CEISAM,
Chimie Et Interdisciplinarité, Synthèse, Analyse, Modélisation, UMR CNRS 6230, UFR des Sciences et des Techniques,
2, rue de la Houssinière, BP 92208, 44322 NANTES Cedex 3, France
| | - François Gaboriau
- INSERM, UMR991, CHRU Pontchaillou, 35033 Rennes, France; Université de Rennes1,
35043 Rennes, France
| |
Collapse
|
44
|
Renaud S, Santelmo N, Renaud M, Fleury MC, De Seze J, Tranchant C, Massard G. Robotic-assisted thymectomy with Da Vinci II versus sternotomy in the surgical treatment of non-thymomatous myasthenia gravis: early results. Rev Neurol (Paris) 2012; 169:30-6. [PMID: 22682054 DOI: 10.1016/j.neurol.2012.02.013] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2011] [Revised: 01/26/2012] [Accepted: 02/13/2012] [Indexed: 10/28/2022]
Abstract
BACKGROUND The role of thymectomy in myasthenia gravis remains controversial. The remission rate 5years after surgery varies from 13 to 51% in the literature. Sternotomy is the standard technique, though unacceptable by patients because of significant esthetic sequelae. Our objective was to demonstrate that the robot-assisted technique using the Da Vinci Surgical Robot II is at least as efficient and leaves fewer scars than the standard surgical technique. METHODS We retrospectively reviewed the data of 31 consecutive patients suffering from myasthenia gravis who underwent surgery in our center from January 1998 to March 2010. Ten patients with thymoma were excluded from this study. Two groups were formed: group 1 corresponding to patients treated with sternotomy, group 2 patients with robot-assisted technique. The duration of the hospital stay, the pain on D1, the degree of improvement at 1year according to Myasthenia Gravis Foundation of America (MGFA) classification, the frequency of relapses, and perioperative treatment were studied. RESULTS Our sample consisted of 14 women and seven men. The mean age was 31.3years. The mean delay before surgery was 24months. Group 1 included 15 patients and group 2 had six patients. The complete remission rate at 1year was 9.5% (n=2). Surgery decreased the frequency of relapses after surgery (P=0.08) equally in the two groups. The duration of hospital stay and the pain level on D1 in group 2 were significantly lower than those in group 1 (P=0.02 and P<0.001). The degree of postoperative improvement was not significantly different between the two groups (P=0.31). CONCLUSION The results at 1year are fully comparable for sternotomy and the robot-assisted technique. The robot provides additional benefits of minimally invasive techniques: minimal esthetic sequelae in often young patients, less parietal morbidity (including pain), shorter hospital stays. Our complete remission rate, lower than those in the literature, must be considered taking into account the early nature of these results. The surgical robot, because of its many advantages, appears to be a promising technique and should facilitate the early management of these patients.
Collapse
Affiliation(s)
- S Renaud
- Service de chirurgie thoracique, pôle de pathologie thoracique, hôpitaux universitaires de Strasbourg, Nouvel Hôpital Civil, 1, place de l'Hôpital, BP 426, 67091 Strasbourg cedex, France
| | | | | | | | | | | | | |
Collapse
|
45
|
Reeb J, Falcoz P, Santelmo N, Mansour Z, Lejay A, Renaud S, Parissiadis A, Hanau D, Kessler R, Massard G. 529 Significance of Anti-HLA Immunization in Lung Transplantation. J Heart Lung Transplant 2012. [DOI: 10.1016/j.healun.2012.01.541] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
46
|
Abstract
Massive hemoptyses are serious clinical conditions that can quickly jeopardize the vital prognosis. The major risk is asphyxiation, due to the bleeding into the tracheobronchial tree. The clinician should provide in parallel support for diagnosis and treatment, locating the bleeding but also finding its cause. Such patients should be cared for by a multidisciplinary team, having quick access to an important technical support. The association fiberoptic bronchoscopy-chest CT scan seems to be the most effective to locate and identify the cause of the bleeding. The development of bronchial artery embolization has revolutionized the management of these patients, replacing surgery in many of its indications. The latter still keeps a place in the management of these patients. Indeed, it is the main etiological treatment, preventing the vast majority of recidivism. It is absolutely indicated in the treatment of bleeding from the pulmonary vessels, and in case of failure of other techniques. It should be performed whenever possible away from the episode of hemoptysis, in order to minimize the operative risk.
Collapse
Affiliation(s)
- S Renaud
- Service de chirurgie thoracique, nouvel hôpital civil, 1 place de l'Hôpital, Strasbourg, France
| | | | | | | |
Collapse
|
47
|
Renaud S, Falcoz PE, Santelmo N, Puyraveau M, Hirschi S, Hentz JG, Quoix E, Massard G. Gastric distension is a contributing factor to pneumonia after pulmonary resection. Eur J Cardiothorac Surg 2012; 42:398-403. [DOI: 10.1093/ejcts/ezs001] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/13/2022] Open
|
48
|
Steck A, Kinter J, Renaud S. [DNA microarray analysis in nerve biopsies of patients with vasculitic neuropathy]. Rev Neurol (Paris) 2011; 167:927-9. [PMID: 22100323 DOI: 10.1016/j.neurol.2011.09.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2011] [Revised: 09/21/2011] [Accepted: 09/24/2011] [Indexed: 11/30/2022]
Abstract
DNA microarray analysis is a powerful tool for simultaneous analysis and comparison of gene products expressed in normal and diseased tissues. We used this technique to identify differentially expressed genes (DEGs) in nerve biopsy samples of vasculitic neuropathy (VAS) patients. We find novel previously uncharacterized genes of relevance to VAS pathogenesis. Genes upregulated in VAS include IGLJ3, IGHG3, IGKC, and IGL, which all function in B-cell selection or antigen recognition of B cells. Other upregulated genes are chemokines, such as CXCL9 and CCR2 and CX3CR1. Allograft inflammatory factor-1 (AIF-1), a modulator of immune response is upregulated in VAS. We demonstrate by immunolocalisation the expression of AIF-1 in vascular smooth muscle cells, suggesting a role for AIF-1 in vascular remodeling in VAS. Microarray-based analysis of human nerve biopsies shows distinct gene expression patterns in VAS. DEGs might provide clues to the pathogenesis of this condition and help define potential targets for therapeutics.
Collapse
Affiliation(s)
- A Steck
- Département de biomédecine, hôpital universitaire de Bâle, Hebelstrasse 20, 4031 Bâle, Suisse.
| | | | | |
Collapse
|
49
|
Abstract
A 30-year analysis of 128 patients with flexor tendon sheath ganglion was investigated. The majority of patients were females with sex ratio of 2.6 : 1. Most of the patients are in their third to fifth decade of life. Hand dominance, previous trauma as well as other illnesses involving the hand did not show any correlation to the formation of ganglion. The middle finger was most commonly affected and 69% of the ganglion were located on A1 and A2 pulley. Recurrence was high (89%) after multiple percutaneous puncture and treatment was successful with no cases of recurrence after surgical excision.
Collapse
Affiliation(s)
- Y Abe
- Department of Orthopaedic Surgery, Saiseikai Shimonoseki General Hospital, Shimonoseki Japan
| | | | | |
Collapse
|
50
|
Kerschgens J, Renaud S, Schütz F, Grasso L, Egener-Kuhn T, Delaloye JF, Lehr HA, Vogel H, Mermod N. Protein-binding microarray analysis of tumor suppressor AP2α target gene specificity. PLoS One 2011; 6:e22895. [PMID: 21876733 PMCID: PMC3158074 DOI: 10.1371/journal.pone.0022895] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2011] [Accepted: 07/08/2011] [Indexed: 12/22/2022] Open
Abstract
Cheap and massively parallel methods to assess the DNA-binding specificity of transcription factors are actively sought, given their prominent regulatory role in cellular processes and diseases. Here we evaluated the use of protein-binding microarrays (PBM) to probe the association of the tumor suppressor AP2α with 6000 human genomic DNA regulatory sequences. We show that the PBM provides accurate relative binding affinities when compared to quantitative surface plasmon resonance assays. A PBM-based study of human healthy and breast tumor tissue extracts allowed the identification of previously unknown AP2α target genes and it revealed genes whose direct or indirect interactions with AP2α are affected in the diseased tissues. AP2α binding and regulation was confirmed experimentally in human carcinoma cells for novel target genes involved in tumor progression and resistance to chemotherapeutics, providing a molecular interpretation of AP2α role in cancer chemoresistance. Overall, we conclude that this approach provides quantitative and accurate assays of the specificity and activity of tumor suppressor and oncogenic proteins in clinical samples, interfacing genomic and proteomic assays.
Collapse
Affiliation(s)
- Jan Kerschgens
- Institute of Biotechnology, University of Lausanne, Lausanne, Switzerland
| | | | | | | | | | | | | | | | | |
Collapse
|